Analyst Conference Summaries

Biotechnology Investor Aids

Vertex Pharmaceuticals
VRTX

conference date: January 25, 2017 @ 1:30 PM Pacific Time

The $300,000 Drug [New York Times, July 18, 2014]
I Still Don't Like Vertex [June 24, 2014]
Vertex Pharmaceuticals: Dog Of The Nasdaq 100? [September 11, 2013]

Analyst Call Notes by William P. Meyers
2016
04/27/2016
07/27/2016
10/25/2016
01/25/2017
2015
04/29/2015
07/29/2014
10/28/2015
01/27/2016
2014
05/01/2014
07/29/2014
10/28/2014
01/28/2015 
2013
07/29/2013
10/29/2013 
01/29/2014

Vertex Pharmaceuticals (VRTX) is a manufacturer of therapies for Cystic Fibrosis and other diseases.

Vertex Pharmaceuticals web site
Vertex Pharmaceuticals investor relations page


 

Search

More Analyst Conference Pages:

 AGEN
 AGIO
 ALNY
 ALXN
 AMAT
 AMD
 AMGN
 BIIB
 BIND
 CLDX
 CELG
 EPZM
 GILD
 GLYC
 HNSN
 INO
 INTC
 ISRG
 JUNO
 MACK
 MCHP
 MDVN
 MYL.
 NVDA
 OPXA
 PLX
 REGN
 SGEN
 XLNX
 XLRN

 

Disclaimer: Our analyst summaries may include both our condensations of statements made by company representatives and our own analysis. They are not covered by any warranty. We cannot guarantee anything said by company representatives is true. We try not to make errors, but it is possible. Before making or terminating an investment you should always verify any factual basis of your decision.

Copyright 2013 William P. Meyers